Page 21234..1020..»

You are currently browsing the Nano Medicine category

Coronavirus’ business impact: Spherical Activated Carbon Market 10-year Forecast and Trends Analysis Research Report – News Distinct

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Coronavirus’ business impact: Spherical Activated Carbon Market 10-year Forecast and Trends Analysis Research Report – News Distinct

The report on the Spherical Activated Carbon market provides a birds eye view of the current proceeding within the Spherical Activated Carbon market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Spherical Activated Carbon market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Spherical Activated Carbon market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.

The Spherical Activated Carbon market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the Spherical Activated Carbon market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2682266&source=atm

The major players profiled in this Spherical Activated Carbon market report include:

Segment by Type, the Spherical Activated Carbon market is segmented into 0.2-0.4mm Particle 0.4-0.6mm Particle 0.6-0.9mm Particle Above 0.9mm Particle Segment by Type, the Spherical Activated Carbon can be split into 0.2-0.4mm Particle, 0.4-0.6mm Particle, etc.

Segment by Application Gas and Waste Water Recovery Clean Room Air and Chemical Filters Polysilicon Production Process Water Treatment Medicine Other Segment by Application, the Spherical Activated Carbon market can be sub-segmented into several major Application, like Gas and Waste Water Recovery, Clean Room Air and Chemical Filters, etc. This section displays the market size by Application in 2020 and forecast to 2026. The CAGR (2020-2026) is based on the volume of Spherical Activated Carbon by Application and the overall market.

Global Spherical Activated Carbon Market: Regional Analysis The Spherical Activated Carbon market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Spherical Activated Carbon market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

Global Spherical Activated Carbon Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Spherical Activated Carbon market include: Kureha Corporation Osaka Gas Chemical Group Kuraray Shanxi Xinhua Chemical

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2682266&licType=S&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2682266&source=atm

Read this article:
Coronavirus' business impact: Spherical Activated Carbon Market 10-year Forecast and Trends Analysis Research Report - News Distinct

Read the Rest...

The impact of the coronavirus on the X-Ray Contrast Agents Market: Future Scenarios and Business Opportunity Analysis 2023 – 3rd Watch News

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on The impact of the coronavirus on the X-Ray Contrast Agents Market: Future Scenarios and Business Opportunity Analysis 2023 – 3rd Watch News

Detailed Study on the Global X-Ray Contrast Agents Market

A recent market study throws light on some of the leading factors that are likely to influence the growth of the X-Ray Contrast Agents market in the upcoming decade. The well-researched market study touches upon the growth potential of various budding market players in the current X-Ray Contrast Agents market landscape. Moreover, established players, stakeholders, and investors can leverage the data in the report to formulate effective growth strategies.

As per the report, the X-Ray Contrast Agents market is forecasted to reach a value of ~US$XX by the end of 2029 and grow at a CAGR of ~XX% through the forecast period (2019-2029). The key dynamics of the X-Ray Contrast Agents market including the drivers, restraints, opportunities, and trends are thoroughly analyzed in the presented report.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2633017&source=atm

The Research Aims to Addresses the Following Doubts Pertaining to the X-Ray Contrast Agents Market

The report on the X-Ray Contrast Agents market provides a birds eye view of the current proceeding within the X-Ray Contrast Agents market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the X-Ray Contrast Agents market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the X-Ray Contrast Agents market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2633017&source=atm

X-Ray Contrast Agents Market Segmentation

Competitive Landscape

The competitive landscape section of the report elaborates on the recent developments and innovations introduced by prominent players in the X-Ray Contrast Agents market. The growth potential, revenue growth, product range, and pricing strategies of each market player in inspected in the report with precision.

End-use Industry Assessment

The report segments the X-Ray Contrast Agents market on the basis of end-use industry and offers a detailed understanding of the supply-demand ratio and consumption pattern of the X-Ray Contrast Agents in each end-use industry.

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the X-Ray Contrast Agents market is segmented into Medical Barium Sulfate Iodine

Segment by Application Hospitals Clinics Other

Global X-Ray Contrast Agents Market: Regional Analysis The X-Ray Contrast Agents market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the X-Ray Contrast Agents market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global X-Ray Contrast Agents Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global X-Ray Contrast Agents market include: Lantheus Medical Imaging Bracco SpA GE Healthcare Daiichi Sankyo Company Bayer Guerbet Group Hengrui Medicine BeiLu Pharmaceutical

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2633017&licType=S&source=atm

Essential Findings of the X-Ray Contrast Agents Market Report:

Link:
The impact of the coronavirus on the X-Ray Contrast Agents Market: Future Scenarios and Business Opportunity Analysis 2023 - 3rd Watch News

Read the Rest...

Securing Medical Technology in the Age of COVID-19 – Infosecurity Magazine

§ May 30th, 2020 § Filed under Nano Medicine Comments Off on Securing Medical Technology in the Age of COVID-19 – Infosecurity Magazine

Consider the miracle of a pacemaker that promotes heartbeat regularity or an insulin pump that ensures a diabetics pancreatic function both are devices operated by a distant network. Now, imagine if those networks were to fail. Particularly in the age of COVID-19, technology experts are feeling the pressure to develop new strategies to tackle healthcare challenges. Cyber threats in the field of medical technology range from hacking of IoT medical devices, such as insulin pumps and pacemakers, to the PHI of cardiac arrest patients being locked by ransomware attackers, thus preventing timely treatment of patients in critical condition due to heart attack.

While thousands of patients utilize such medical devices, the security of these systems lies with the networks remotely powering the device. Moreover, nanomedicine or the use of nantotechnology for healthcare purposes such as eradication of cancer cells also relies on such distant networks. Like any computer network, SCADA systems face risks from a variety of cyber-attacks.

Recently, Dr. Gregory Carpenter, a Cyber Epidemiologist at KnowledgeBridge International Inc., has revealed his teams investigation results, including the discovery that 23 of the 25 bio-nano carrier networks tested were vulnerable to basic DDoS attacks, as well as other legacy threats such as outdated and unpatched systems exposed to zero-day attacks.

The operational nature of SCADA especially in healthcare remains highly collaborative, with medical staff sharing data amongst themselves as well as hospital IT teams sharing information with cloud brokers and providers. Indeed, as more medical organizations migrate to the cloud, such data sharing coupled with the lack of visibility inherent to the cloud environment poses many risks.

As the attack surface increases l with both medical IoT and PHIs exposure to the cloud, hospitals and medical device providers could benefit from ensuring that patient information is encrypted and their cloud providers have secure defenses in place against denial of service attacks.

In the area of cloud security, healthcare organizations should e bear in mind that while their cloud service providers control the physical security of the servers in their data centers, as cloud customers, the organizations themselves hold responsibility for encrypting data in transit. Therefore, all data whether PHI or related to the operations of medical technology should remain top priority for in-transit security.

In-transit encryption best practices involve the key elements of defining data protection requirements, implementing secure certificate and stored key management, automating data leak detection and authenticating network communications via IPSec or TLS protocols. Such steps to enforcement will help assure that data moving between the cloud provider and healthcare entity endpoint remains secure.

A helpful starting point might entail configuring load balancers to only interact with HTTPS traffic in order to promote encrypted movement of data between the host organization and cloud service provider. Another solution to in-transit security lies in the use of VPN between the cloud provider and healthcare customer. Additionally, both provider and customer must maintain cognizance surrounding faults in availability, in terms of impact to quality of care as well as implications regarding the potential underlying context of such events.

In particular, phishing campaigns have often worked in parallel to larger-scale attacks such as DDoS, in an attempt to infiltrate the target network while security teams focus on the availability-based incident. Therefore, healthcare senior management and IT personnel who observe compromise attempts via network intrusion detection data can help safeguard against a breach by warning all employees to remain vigilant regarding potential phishing emails.

As email-based attacks have especially targeted the healthcare industry amidst the recent COVID-19 crisis, medical professionals and their patients stand to gain the most from hospital management and practitioners learning how to avoid such correlated threats.

To this effect, security awareness training provides an optimal defense against the possibility for data compromise by human error. With fewer physicians and hospital administrators falling victim to scareware and other malicious email-based activity, the attack vector shrinks for cyber-criminals looking to capitalize on the panic over the current global pandemic.

Furthermore, network administrators in the healthcare space can do their part by tightly monitoring infrastructure for any penetration attempt. A place to begin might be examining signs of botnet activity and other availability-based attacks with phishing attempts that occur within a similar timeframe of around 24 hours or fewer. As soon as a security team detects a compromise, all associated medical devices must be immediately remotely deactivated.

Perhaps most importantly, providers of biotechnology as well as hospital services must maintain transparency with all customers and patients regarding any suspected or successful breaches. After all, the individuals receiving treatment in these instances face the highest risk, as any successful attacker holds the power to not only access PHI, but potentially also to hack into a medical device on which a human life might depend.

Sarah Katz is an author working in information security at NASA. Since graduating from UC Berkeley, she has published various pieces in research and science fiction, primarily surrounding the intersection of medicine and technology. Most recently, she has founded Cysec Health, a nonprofit group of cybersecurity volunteers supporting women's health organizations amid the COVID-19 pandemic.

Originally posted here:
Securing Medical Technology in the Age of COVID-19 - Infosecurity Magazine

Read the Rest...

Nanobiotix Announces Positive First Results From Phase I Expansion in Locally Advanced Head and Neck Cancer at ASCO 2020 – Press Release – Digital…

§ May 30th, 2020 § Filed under Nano Medicine Comments Off on Nanobiotix Announces Positive First Results From Phase I Expansion in Locally Advanced Head and Neck Cancer at ASCO 2020 – Press Release – Digital…

PARIS & CAMBRIDGE, Mass.--(Business Wire)--Regulatory News:

NANOBIOTIX (Paris:NANO)(Euronext: NANO - ISIN: FR0011341205 the Company), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced new data from the expansion part of its phase I trial, evaluating the potential of first-in-class NBTXR3 activated by radiation therapy to improve treatment outcomes for elderly patients with locally advanced head and neck cancer ineligible for chemotherapy or intolerant to cetuximab. The data were published as part of the virtual scientific program at the 2020 annual meeting of the American Society for Clinical Oncology (ASCO).

Study 102: A phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients

Authors: Christophe Le Tourneau, Valentin Calugaru, Edith Borcoman, Victor Moreno, Emiliano Calvo, Xavier Liem, Sebastien Salas, Bernard Doger, Olivier Choussy, Maria Lesnik, Xavier Mirabel, Nathalie Badois, Samar Krhili, Josefin Blomkvist, Nicolas Fakhry, Stphanie Wong-Hee-Kam, Caroline Hoffmann.

J Clin Oncol 38: 2020 (suppl; abstr 6573). DOI: 10.1200/JCO.2020.38.15_suppl.6573.

Abstract Number: 6573

Study Design

After reporting promising early signs of activity from the dose escalation part of its phase I trial evaluating the safety and feasibility of NBTXR3 activated by radiation therapy in elderly patients with locally advanced head and neck squamous cell carcinoma (HNSCC), the Company launched an expansion cohort to confirm results and observed trends with a larger population treated at the recommended dose. This part of the study is expected to recruit a total of 44 evaluable patients. To date, 40 patients have been recruited, 30 of whom are evaluable for efficacy and are included in the data presented at ASCO 2020.

Topline Results

As previously announced, in the dose escalation part of the study NBTXR3 activated by radiation therapy was safe and well tolerated. The recommended phase 2 dose (RP2D) was determined to be 22% of baseline tumor volume. Among 16 evaluable patients, injected lesion complete response rate was 56% and overall objective response rate was 69%.

Regarding the new, expansion part data, analysis of 40 patients dosed showed that NBTXR3 activated by radiation therapy remains safe and well tolerated. In terms of efficacy, for the 30 evaluable patients, investigators observed, at a median time of 5 months after NBTXR3 injection, an overall objective response rate of 83% and an overall complete response rate of 43% and objective response rate of the primary tumor (target lesion) of 83% with a complete response rate of the primary tumor of 60%. The safety profile was consistent with the dose escalation part and the efficacy data improved (i.e. an increase in overall objective response rate from 69% in the dose escalation part to 83% in the dose expansion part).

In the safety population (all treated patients, N=40), three serious adverse events (SAEs) related to NBTXR3 were observed (0.7% of all AEs), comprising one case each of: Grade 4 tumor hemorrhage also related to radiotherapy, Grade 3 mucosal inflammation and Grade 2 swollen tongue also related to the injection procedure. Two SAEs related to the injection procedure were reported (0.5% of all AEs), comprising: two cases of swollen tongue, of which one was Grade 2 and also related to NBTXR3, and one was Grade 4. The radiotherapy-associated safety profile was as expected with the most frequently occurring AEs being stomatitis and skin injury. Three deaths due to AEs related to radiotherapy and other causes were observed. Four other patients died of non-oncologic or non-toxicity-related reasons.

Next Steps in Head and Neck Cancer

The expansion part of the phase I trial will continue to recruit until reaching 44 evaluable patients. In parallel, subject to the FDAs pending review, the Company intends to globally launch a pivotal phase III trial. In the planned phase III trial, a futility analysis is expected 18 months after the first patient is randomized, and an interim analysis of progression-free survival (PFS) is expected at 24-30 months.

NBTXR3 for the treatment of locally advanced HNSCC patients who are not eligible for platinum-based chemotherapy received Fast Track designation from the FDA in February 2020. Fast Track designation is a process designed to facilitate the development and accelerate the review of drugs for serious conditions that have the potential to address unmet medical needs. The purpose is to expedite the availability of new treatment options for patients.

About NBTXR3

NBTXR3 is a first-in-class product designed to destroy tumors through physical cell death when activated by radiotherapy. NBTXR3 has a high degree of biocompatibility, requires one single administration before the first radiotherapy treatment session, and has the ability to fit into current worldwide radiation therapy standards of care. The physical mode of action of NBTXR3 makes it applicable across solid tumors.

NBTXR3 is being evaluated in locally advanced head and neck squamous cell carcinoma (HNSCC) of the oral cavity or oropharynx in elderly patients unable to receive chemotherapy or cetuximab with limited therapeutic options. Promising results have been observed in the phase I trial regarding local control. In the United States, the Company has started the regulatory process to commence a phase III clinical trial in locally advanced head and neck cancers.

Nanobiotix is also running an Immuno-Oncology development program. The Company has launched a Phase I clinical trial of NBTXR3 activated by radiotherapy in combination with anti-PD-1 checkpoint inhibitors in locoregional recurrent (LRR) or recurrent and metastatic (R/M) HNSCC amenable to re-irradiation of the HN and lung or liver metastases (mets) from any primary cancer eligible for anti-PD-1 therapy.

Other ongoing NBTXR3 trials are treating patients with hepatocellular carcinoma (HCC) or liver metastases, locally advanced or unresectable rectal cancer in combination with chemotherapy, head and neck cancer in combination with concurrent chemotherapy, and pancreatic cancer. The Company has a broad, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center (initially expected to support 9 new clinical trials in the United States) to evaluate NBTXR3 across several cancer types.

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France, with a US affiliate in Cambridge, MA, and European affiliates in France, Spain and Germany.

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the universal registration document of Nanobiotix approved by the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.20-010 on May 12, 2020 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200529005528/en/

Nanobiotix Communications Department Brandon Owens +1 (617) 852-4835 contact@nanobiotix.com

Investor Relations Department Ricky Bhajun +33 (0)1 79 97 29 99 investors@nanobiotix.com

Media Relations France TBWA Corporate Pauline Richaud + 33 (0) 437 47 36 42 Pauline.richaud@tbwa-corporate.com

US RooneyPartners Marion Janic +1 (212) 223-4017 mjanic@rooneyco.com

Go here to read the rest:
Nanobiotix Announces Positive First Results From Phase I Expansion in Locally Advanced Head and Neck Cancer at ASCO 2020 - Press Release - Digital...

Read the Rest...

Nanobots Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| Xidex Corp, Zymergen Inc, Synthace Limited, Ginkgo…

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Nanobots Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| Xidex Corp, Zymergen Inc, Synthace Limited, Ginkgo…

LOS ANGELES, United States:QY Research has recently published a report, titled Global Nanobots Market Research Report 2020-2026.The research report provides an in-depth explanation of the various factors that are likely to drive the market. It discusses the future of the market by studying the historical details. Analysts have studied the ever-changing market dynamics to evaluate their impact on the overall market. In addition, the Nanobots report also discusses the segments present in the market. Primary and secondary research methodologies have been used to provide the readers with an accurate and precise understanding of the overall Nanobots market. Analysts have also given readers an unbiased opinion about the direction companies will take during the forecast period.

The research report also includes the global Nanobots market figures that provide historical data as well as estimated figures. It gives a clear picture of the growth rate of the market during the forecast period. The Nanobots report aims to give the readers quantifiable data that is collected from verified data. The report attempts to answer all the difficult questions such as market sizes and company strategies.

Download Full PDF Sample Copy ofNanobots Report with TOC, figure and tables: https://www.qyresearch.com/sample-form/form/1738855/impact-of-covid-19-outbreak-on-nanobots-global-and-japan-market

The vendor landscape and competitive scenarios of the global Nanobots market are broadly analyzed to help market players gain competitive advantage over their competitors. Readers are provided with detailed analysis of important competitive trends of the global Nanobots market. Market players can use the analysis to prepare themselves for any future challenges well in advance. They will also be able to identify opportunities to attain a position of strength in the global Nanobots market. Furthermore, the analysis will help them to effectively channelize their strategies, strengths, and resources to gain maximum advantage in the global Nanobots market.

Key Players Mentioned in the Global Nanobots Market Research Report: Xidex Corp, Zymergen Inc, Synthace Limited, Ginkgo Bioworks, Advanced Diamond Technologies, Advanced Nano Products Co Limited

Global Nanobots Market Segmentation by Product: Microbivore Nanorobots, Respirocyte Nanorobots, Clottocyte Nanorobots, Cellular Repair Nanorobots

Global Nanobots Market Segmentation by Application: Nano Medicine, Biomedical, Mechanical, Other applications

The report comes out as an accurate and highly detailed resource for gaining significant insights into the growth of different product and application segments of the global Nanobots market. Each segment covered in the report is exhaustively researched about on the basis of market share, growth potential, drivers, and other crucial factors. The segmental analysis provided in the report will help market players to know when and where to invest in the global Nanobots market. Moreover, it will help them to identify key growth pockets of the global Nanobots market.

Key Questions Answered

Request for customization in Report:https://www.qyresearch.com/customize-request/form/1738855/impact-of-covid-19-outbreak-on-nanobots-global-and-japan-market

Table of Content

1 Study Coverage 1.1 Nanobots Product Introduction 1.2 Market Segments 1.3 Key Nanobots Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Nanobots Market Size Growth Rate by Type 1.4.2 Microbivore Nanorobots 1.4.3 Respirocyte Nanorobots 1.4.4 Clottocyte Nanorobots 1.4.5 Cellular Repair Nanorobots 1.5 Market by Application 1.5.1 Global Nanobots Market Size Growth Rate by Application 1.5.2 Nano Medicine 1.5.3 Biomedical 1.5.4 Mechanical 1.5.5 Other applications 1.6 Coronavirus Disease 2019 (Covid-19): Nanobots Industry Impact 1.6.1 How the Covid-19 is Affecting the Nanobots Industry 1.6.1.1 Nanobots Business Impact Assessment Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Nanobots Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Nanobots Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered

2 Executive Summary 2.1 Global Nanobots Market Size Estimates and Forecasts 2.1.1 Global Nanobots Revenue 2015-2026 2.1.2 Global Nanobots Sales 2015-2026 2.2 Nanobots Market Size by Region: 2020 Versus 2026 2.3 Nanobots Historical Market Size by Region (2021-2026) 2.3.1 Global Nanobots Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Nanobots Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Nanobots Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Nanobots Sales Forecast by Region (2021-2026) 2.4.2 Global Nanobots Revenue Forecast by Region (2021-2026)

3 Global Nanobots Competitor Landscape by Players 3.1 Global Top Nanobots Sales by Manufacturers 3.1.1 Global Nanobots Sales by Manufacturers (2015-2020) 3.1.2 Global Nanobots Sales Market Share by Manufacturers (2015-2020) 3.2 Global Nanobots Manufacturers by Revenue 3.2.1 Global Nanobots Revenue by Manufacturers (2015-2020) 3.2.2 Global Nanobots Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Nanobots Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Nanobots Revenue in 2019 3.2.5 Global Nanobots Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Nanobots Price by Manufacturers 3.4 Global Nanobots Manufacturing Base Distribution, Product Types 3.4.1 Nanobots Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Nanobots Product Type 3.4.3 Date of International Manufacturers Enter into Nanobots Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026) 4.1 Global Nanobots Market Size by Type (2015-2020) 4.1.1 Global Nanobots Sales by Type (2015-2020) 4.1.2 Global Nanobots Revenue by Type (2015-2020) 4.1.3 Nanobots Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Nanobots Market Size Forecast by Type (2021-2026) 4.2.1 Global Nanobots Sales Forecast by Type (2021-2026) 4.2.2 Global Nanobots Revenue Forecast by Type (2021-2026) 4.2.3 Nanobots Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Nanobots Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026) 5.1 Global Nanobots Market Size by Application (2015-2020) 5.1.1 Global Nanobots Sales by Application (2015-2020) 5.1.2 Global Nanobots Revenue by Application (2015-2020) 5.1.3 Nanobots Price by Application (2015-2020) 5.2 Nanobots Market Size Forecast by Application (2021-2026) 5.2.1 Global Nanobots Sales Forecast by Application (2021-2026) 5.2.2 Global Nanobots Revenue Forecast by Application (2021-2026) 5.2.3 Global Nanobots Price Forecast by Application (2021-2026)

6 China by Players, Type and Application 6.1 China Nanobots Market Size YoY Growth 2015-2026 6.1.1 China Nanobots Sales YoY Growth 2015-2026 6.1.2 China Nanobots Revenue YoY Growth 2015-2026 6.1.3 China Nanobots Market Share in Global Market 2015-2026 6.2 China Nanobots Market Size by Players (International and Local Players) 6.2.1 China Top Nanobots Players by Sales (2015-2020) 6.2.2 China Top Nanobots Players by Revenue (2015-2020) 6.3 China Nanobots Historic Market Review by Type (2015-2020) 6.3.1 China Nanobots Sales Market Share by Type (2015-2020) 6.3.2 China Nanobots Revenue Market Share by Type (2015-2020) 6.3.3 China Nanobots Price by Type (2015-2020) 6.4 China Nanobots Market Estimates and Forecasts by Type (2021-2026) 6.4.1 China Nanobots Sales Forecast by Type (2021-2026) 6.4.2 China Nanobots Revenue Forecast by Type (2021-2026) 6.4.3 China Nanobots Price Forecast by Type (2021-2026) 6.5 China Nanobots Historic Market Review by Application (2015-2020) 6.5.1 China Nanobots Sales Market Share by Application (2015-2020) 6.5.2 China Nanobots Revenue Market Share by Application (2015-2020) 6.5.3 China Nanobots Price by Application (2015-2020) 6.6 China Nanobots Market Estimates and Forecasts by Application (2021-2026) 6.6.1 China Nanobots Sales Forecast by Application (2021-2026) 6.6.2 China Nanobots Revenue Forecast by Application (2021-2026) 6.6.3 China Nanobots Price Forecast by Application (2021-2026)

7 North America 7.1 North America Nanobots Market Size YoY Growth 2015-2026 7.2 North America Nanobots Market Facts & Figures by Country 7.2.1 North America Nanobots Sales by Country (2015-2020) 7.2.2 North America Nanobots Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada

8 Europe 8.1 Europe Nanobots Market Size YoY Growth 2015-2026 8.2 Europe Nanobots Market Facts & Figures by Country 8.2.1 Europe Nanobots Sales by Country 8.2.2 Europe Nanobots Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia

9 Asia Pacific 9.1 Asia Pacific Nanobots Market Size YoY Growth 2015-2026 9.2 Asia Pacific Nanobots Market Facts & Figures by Country 9.2.1 Asia Pacific Nanobots Sales by Region (2015-2020) 9.2.2 Asia Pacific Nanobots Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam

10 Latin America 10.1 Latin America Nanobots Market Size YoY Growth 2015-2026 10.2 Latin America Nanobots Market Facts & Figures by Country 10.2.1 Latin America Nanobots Sales by Country 10.2.2 Latin America Nanobots Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina

11 Middle East and Africa 11.1 Middle East and Africa Nanobots Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Nanobots Market Facts & Figures by Country 11.2.1 Middle East and Africa Nanobots Sales by Country 11.2.2 Middle East and Africa Nanobots Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E

12 Company Profiles 12.1 Xidex Corp 12.1.1 Xidex Corp Corporation Information 12.1.2 Xidex Corp Description, Business Overview and Total Revenue 12.1.3 Xidex Corp Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Xidex Corp Nanobots Products Offered 12.1.5 Xidex Corp Recent Development 12.2 Zymergen Inc 12.2.1 Zymergen Inc Corporation Information 12.2.2 Zymergen Inc Description, Business Overview and Total Revenue 12.2.3 Zymergen Inc Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Zymergen Inc Nanobots Products Offered 12.2.5 Zymergen Inc Recent Development 12.3 Synthace Limited 12.3.1 Synthace Limited Corporation Information 12.3.2 Synthace Limited Description, Business Overview and Total Revenue 12.3.3 Synthace Limited Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Synthace Limited Nanobots Products Offered 12.3.5 Synthace Limited Recent Development 12.4 Ginkgo Bioworks 12.4.1 Ginkgo Bioworks Corporation Information 12.4.2 Ginkgo Bioworks Description, Business Overview and Total Revenue 12.4.3 Ginkgo Bioworks Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Ginkgo Bioworks Nanobots Products Offered 12.4.5 Ginkgo Bioworks Recent Development 12.5 Advanced Diamond Technologies 12.5.1 Advanced Diamond Technologies Corporation Information 12.5.2 Advanced Diamond Technologies Description, Business Overview and Total Revenue 12.5.3 Advanced Diamond Technologies Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Advanced Diamond Technologies Nanobots Products Offered 12.5.5 Advanced Diamond Technologies Recent Development 12.6 Advanced Nano Products Co Limited 12.6.1 Advanced Nano Products Co Limited Corporation Information 12.6.2 Advanced Nano Products Co Limited Description, Business Overview and Total Revenue 12.6.3 Advanced Nano Products Co Limited Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Advanced Nano Products Co Limited Nanobots Products Offered 12.6.5 Advanced Nano Products Co Limited Recent Development 12.11 Xidex Corp 12.11.1 Xidex Corp Corporation Information 12.11.2 Xidex Corp Description, Business Overview and Total Revenue 12.11.3 Xidex Corp Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Xidex Corp Nanobots Products Offered 12.11.5 Xidex Corp Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porters Five Forces Analysis 13.5 Primary Interviews with Key Nanobots Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Nanobots Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

About Us:

We established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

See the original post:
Nanobots Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| Xidex Corp, Zymergen Inc, Synthace Limited, Ginkgo...

Read the Rest...

Public health cynics hated pandemic interventions in 1918, too – Crosscut

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Public health cynics hated pandemic interventions in 1918, too – Crosscut

Historian Nancy Rockafellar, writing about the flu pandemic in a 1986 Pacific Northwest Quarterly article, In Gauze We Trust, looked at public attitudes following the epidemic. The public, she wrote, resisted regulative zeal on the part of public health officials. Science had not understood influenza enough to prevent catastrophic losses. As a result, The devastating epidemic had seriously dimmed postwar optimism and faith in the application of progressive medical science. Despite scientific advances and a greater medical community commitment to public health, the concept and actual well-being of society suffered a stunning defeat in the immediate aftermath of World War I, she concluded.

Read the rest of Knute Berger's ongoing series on the impacts of the 1918 flu in the Pacific Northwest.

Selling public health in the early 20th century had been an uphill struggle the more it was applied. Some people resisted any interference in their lives, even in the name of public health. In 1911, Dr. Eugene Porter, New Yorks state health commissioner, succinctly articulated the challenge of trying to overcome public resistance to changing behavior in order to stop preventable diseases: Blocking our way stand the troops of selfishness and ignorance. These are always the twin foes of progress.

To that end, Washingtons public health officials worked to gain support for their work even before the pandemic. Typhoid, diphtheria, scarlet fever, measles, smallpox all demanded attention, as did water quality and sanitation. State inspectors traveled Washington to track down the sources of disease, test milk, inspect logging camps and test samples in a state laboratory designed for the purpose. In the war years, venereal or social diseases had become rampant. Tuberculosis was an ongoing problem. Both VD and TB were often treated by segregating patients from the rest of society.

Both World War I-era state health commissioners, Dr. Thomas D. Tuttle of Seattle and his successor, Dr. John B. Anderson of Spokane, had battled the flu pandemic and both likened the financing of the states public health efforts to war. In a typescript report on public health to Washington Gov. Louis F. Hart in 1920, Anderson wrote, Our citizens are willing to be taxed for protection against an armed foe who would invade our homes and openly destroy life and property, but it is very difficult for me to comprehend why people are unwilling to pay relatively small sums for doing those things that will save from death many who might perish from microscopic enemies. Anderson recommended that the state buy and provide a diphtheria antitoxin free to the public. As it was, it was free only to the poor and cheap for the rich, but unaffordable to the vast middle.

Dr. Thomas D. Tuttle (Washington State Archives/Medical license record

Anticipating the rough circumstances for selling public health to the Legislature and citizens around the state, Tuttle used his 1915-1916 Biennial State Health Report to compose what amounted to a public health manifesto arguing for funding, acceptance and education. He invoked thinkers such as author and critic John Ruskin and philosopher Herbert Spencer to bolster his case.

First, Tuttle identified the enemy by quoting from Spencer a passage popular among public health advocates in the late 19th century: Ignorant men may sneer at the pretentions of sanitary science; weak and timorous men may hesitate to commit themselves to its principles, so large is their affliction; selfish men may shrink from the labor of change, which its recognition must entail; and wicked men may turn indifferently from considering that which concerns the health and happiness of millions of their fellow creatures. Spencer went on to say that public health work was the essence of Christian behavior.

Having set the battle lines between modern medicine and the ignorant, timid and wicked, Tuttle then argued for economic pragmatism. In preventable diseases we have for reflection a condition of urgent economic importance. They are destructive to efficient manpower; are unnecessary and can be restrained, and possibly entirely suppressed. Lack of health, in other words, was bad for business.

Even so, selling the idea was not going to be easy. Our efforts at control will meet with opposition opposed on the ground that we are restraining the individual from exercising his right of liberty, Tuttle wrote. He dismissed such arguments: Any claim to vested rights to liberty which disregards the neighbors vested rights to liberty is properly catalogued as despotic selfishness. In other words, your mask or quarantine or vaccination protects the liberty of the whole community. Dont Tread on Me doesnt give one the right to tread on others by exposing them to disease.

Tuttle also argued that there was a larger, more long-lasting obligation. He leaned on biblical notions to support his case that public health is pro-life: We are willingly taxing ourselves for every commodity in daily use that the war burden may not fall upon the babes of the next, or the next and yet the next generation! This is proof of the working of a sub-conscious law of fair play which avouches the right of the unconceived child to be represented before the bar of equity concerning economic measures. I contend that the unborn child has the same right to be protected from sociological, environmental and disease producing conditions. A true bill or indictment would lie against any forbears who neglected to hand down a heritage of good health, and it is well to remember that the sins of the fathers are visited upon the children even unto the third and fourth generation. Tuttle saw public health as protecting the rights of people yet to come, a similar argument made today by environmentalists regarding climate change.

Despite his articulate passion, Tuttle was fired from his job in early 1919 after steering the state through the worst of the Spanish flu pandemic. The trigger was politics defiant Olympia and Thurston County doctors who opposed further shutdowns and he left the state shortly after. His successor, Anderson, who was the chief health officer and physician in Spokane before and during the flu epidemic, was appointed as Tuttles replacement. Faced with writing his first state-of-the-state health report in early 1920, Anderson lifted nearly all of Tuttles manifesto with a few additional paragraphs of his own to make his argument for a bigger budget, better pay for health commission staff, and more funding to sell the idea of public health to the general public.

Dr. John B. Anderson(Spokane Chronicle, 1916)

Anderson also picked up Tuttles notion of responsibility to the future, as newspapers of the time noted that he gave lectures on the Responsibility to Posterity to various civic and health groups around the state. But by 1921 he too was fired, the health commission reorganized, and its budget, at least temporarily, reduced. When asked by the Spokesman-Review about leaving the job, the paper reported Anderson would not discuss the change in the management of state health affairs beyond expressing the belief that politics has nothing to offer a professional man. Anderson also left the state for work, it was reported, with the U.S. Public Health Service.

This brings to mind a quote attributed to John Ruskin that both Tuttle and Anderson included in their reports, which perhaps reflects the frustration public health officials felt in the face of opposition: Any regulations which tend to improve the health of the masses are viewed by them as an unwarranted interference with their vested rights in inevitable disease and death.

The quote, used in arguments promoting public health at the turn of the century, was sometimes said to be meant cynically or sarcastically. Yet, by invoking it, Washingtons public health officials were laying a moral marker for policies designed to not only help the living, but to fulfill a duty to the coming generations even if many of their fellow citizens in the present resist treatment.

Read the original:
Public health cynics hated pandemic interventions in 1918, too - Crosscut

Read the Rest...

Health care providers open for business, urge those in need of care not to wait – News-Leader

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Health care providers open for business, urge those in need of care not to wait – News-Leader

A global pandemic that creates a huge need for health care is also delivering a financial blow to that sector. (May 18) AP Domestic

Local health care providers spent much of the past few months focused on the front lines of the pandemic, treating coronavirus patients and preparing for the feared surge.

Theyre still doing all that. CoxHealth just finished treating its first patient with the experimental drug remdesivir, which researchers hope will reduce recovery times of serious cases. Cox and Mercy are still offering free virtual visits to patients who need a COVID-19 consultation and covering the cost of tests, too. And Cox has a new 51-bed coronavirus ICU on standby just in case.

But with the local curve largely flattened," Springfields major hospitals are re-opening their operating rooms to patients who need surgeries unrelated to the coronavirus so they dont have to wait until its too late.

Missouri Governor Mike Parson, right, speaks with CoxHealth president and CEO Steve Edwards while touring the coronavirus ward at Cox South on Monday, May 4, 2020.(Photo: Andrew Jansen/News-Leader)

At the height of the crisis, CoxHealth postponed nearly 6,000 surgeries and procedures for safety and space, spokeswoman Kaitlyn McConnell said.

Now the system is back up to around 90 percent of normal capacity and cleaning has been stepped up to make sure patients stay safe.

In some cases, high-touch areas such as door handles and elevator buttons are cleaned four times as frequently as they were before, McConnell said. We also have technology at our hospitals, such as a Xenex-light robot, which kills bacteria and viruses at a microscopic level, and a bleach 'gun' that can be used to sterilize surfaces on contact.

The same tactics are in use at Cox's clinics and urgent cares, which McConnell said never closed to patients who needed care, to make sure the virus doesn't take root there.

"We want to remind patients that their care is essential," she said. "We are prepared to care for patients if and when they need us, and are working to ensure that their experience is a safe one."

Missouri Governor Mike Parson, left, speaks after touring the coronavirus ward at Cox South on Monday, May 4, 2020. Also pictured is CoxHealth president and CEO Steve Edwards.(Photo: Andrew Jansen/News-Leader)

Similar work is going on up the road at Mercy, where clinics are asking patients to wait for appointments in their cars to avoid the waiting room and disinfecting exam rooms after every patient visit to avoid transmission.

Clinics are also screening visitors at the door to ensure theyre not bringing the virus with them inside.

With all of these measures in place, we firmly believe that the only place safer than our offices is your own home, Dr. Raymond Weick, who works in family medicine at Mercy, said in a recent video.

Independent clinics are also working patients in different ways.

The story continues below.

Dr. Shelby Smith at Equality Healthcare said his practices model, where patients pay a monthly fee for their care like they would for a Netflix subscription, has thrived amid the crisis.

He already kept in touch with hundreds of patients over text since the monthly fee covers the cost, and now does more of it.

Our business model doesnt require people to come in and so we transition pretty easily to phone and email," he said. I treated a COPD exacerbation over the phone this morning.

Austin Huguelet is the News-Leader's politics reporter. Got something he should know? Have a question? Call him at 417-403-8096 or email him at ahuguelet@news-leader.com. You can also support local journalism at News-Leader.com/subscribe.

Read or Share this story: https://www.news-leader.com/story/news/local/ozarks/2020/05/28/springfield-health-care-mercy-coxhealth-open-amid-coronavirus-covid-19/5216132002/

More:
Health care providers open for business, urge those in need of care not to wait - News-Leader

Read the Rest...

COVID-19: Responding to the business impacts of Spinal Muscular Atrophy Medicine Market Outlook With Industry Review and Forecasts – Jewish Life News

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on COVID-19: Responding to the business impacts of Spinal Muscular Atrophy Medicine Market Outlook With Industry Review and Forecasts – Jewish Life News

A recent market study on the global Spinal Muscular Atrophy Medicine market reveals that the global Spinal Muscular Atrophy Medicine market is expected to reach a value of ~US$ XX by the end of 2029 growing at a CAGR of ~XX% during the forecast period (2019-2029).

The Spinal Muscular Atrophy Medicine market study includes a thorough analysis of the overall competitive landscape and the company profiles of leading market players involved in the global Spinal Muscular Atrophy Medicine market. Further, the presented study offers accurate insights pertaining to the different segments of the global Spinal Muscular Atrophy Medicine market such as the market share, value, revenue, and how each segment is expected to fair post the COVID-19 pandemic.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2633762&source=atm

The following doubts are addressed in the market report:

Key Highlights of the Spinal Muscular Atrophy Medicine Market Report

The presented report segregates the Spinal Muscular Atrophy Medicine market into different segments to ensure the readers gain a complete understanding of the different aspects of the Spinal Muscular Atrophy Medicine market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2633762&source=atm

Segmentation of the Spinal Muscular Atrophy Medicine market

Competitive Outlook

This section of the report throws light on the recent mergers, collaborations, partnerships, and research and development activities within the Spinal Muscular Atrophy Medicine market on a global scale. Further, a detailed assessment of the pricing, marketing, and product development strategies adopted by leading market players is included in the Spinal Muscular Atrophy Medicine market report.

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Spinal Muscular Atrophy Medicine market is segmented into LMI-070 ND-602 NT-1654 Nusinersen NXD-30001 Others

Segment by Application Hospital Clinic Others

Global Spinal Muscular Atrophy Medicine Market: Regional Analysis The Spinal Muscular Atrophy Medicine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Spinal Muscular Atrophy Medicine market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Spinal Muscular Atrophy Medicine Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Spinal Muscular Atrophy Medicine market include: Astellas Pharma Inc. AveXis, Inc. Bioblast Pharma Ltd. Cytokinetics, Inc. 24 F. Hoffmann-La Roche Ltd. Genethon Genzyme Corporation GMP-Orphan SAS Ionis Pharmaceuticals, Inc. Longevity Biotech, Inc Neurodyn Inc. Neurotune AG Novartis AG Sarepta Therapeutics, Inc. Voyager Therapeutics, Inc. Vybion, Inc. WAVE Life Sciences Ltd.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2633762&licType=S&source=atm

Link:
COVID-19: Responding to the business impacts of Spinal Muscular Atrophy Medicine Market Outlook With Industry Review and Forecasts - Jewish Life News

Read the Rest...

There are three Fs in biodiversity – Mirage News

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on There are three Fs in biodiversity – Mirage News

So what do you know about biodiversity in Wodonga?

As part of the lead up to World Environment Day on June 5, our Natural Resources Planner Claire Coulson takes a look at bioversity and in particular fungi.

We all know about flora and fauna, but what about fungi?

Not a plant. Not an animal. But scientists estimate that 25 per cent of the worlds living matter is fungal.

In Wodonga, a wet and sunny autumn has produced an abundance of fungi, she said.

You may have seen fungi or mushrooms in your yard, nature strip or local park.

But what you see above the ground is just the tip of the iceberg.

The mushrooms or toadstools you see are just the fruiting part of a much large living organism.

Most of the fungi is actually underground, a network of microscopic root like structures that can extend as far as five kilometres.

The fungal network or mycelium can grow and spread throughout the soil or wrap around plant roots.

They break down dead material, keep soils stable after fire, help plants access nutrients and fight off disease, are essential for agricultural production, are used in medicine, as hallucinogens, they are a food source for people and animals, some are poisonous and have been regarded with suspicion and awe for thousands of years.

A recent estimate of global fungal diversity is 2.2 to 3.8 million species. Just 80,000 species have been studied and described.

Excerpt from:
There are three Fs in biodiversity - Mirage News

Read the Rest...

Precision Medicine Software Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 – Cole of Duty

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Precision Medicine Software Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 – Cole of Duty

New Jersey, United States, The Precision Medicine Software Market report examines the market situation and prospects and represents the size of the Precision Medicine Software market (value and volume) and the share by company, type, application and region. The general trends and opportunities of Precision Medicine Software are also taken into account when examining the Precision Medicine Software industry. Precision Medicine Software The market report focuses on the following section: Analysis of the Precision Medicine Software industry by transfer into different segments; the main types of products that fall within the scope of the report.

This Precision Medicine Software market report is a complete analysis of the Precision Medicine Software market based on an in-depth primary and secondary analysis. The scope of the Precision Medicine Software market report includes global and regional sales, product consumption in terms of volume and value. The Precision Medicine Software market report contains an estimate of revenue, CAGR and total revenue. The knowledge gathered in world trade Precision Medicine Software is presented in figures, tables, pie charts and graphics.

Get | Research Sample Copy By Using Corporate Mail ID @https://www.verifiedmarketresearch.com/download-sample/?rid=27982&utm_source=COD&utm_medium=007

Top 10 Companies in the Global Precision Medicine Software Market Research Report:

Global Precision Medicine Software Market: Drivers and Restrains

The research report included analysis of various factors that increase market growth. These are trends, restrictions and drivers that change the market positively or negatively. This section also contains information on various segments and applications that may affect the market in the future. Detailed information is based on current trends and historical milestones. This section also includes an analysis of sales volume on the Precision Medicine Software market and for each type from 2015 to 2026. This section mentions sales volume by region from 2015 to 2026. The price analysis is included in the report Type of year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020 and total price from 2015 to 2026.

An in-depth assessment of the restrictions contained in the report describes the contrast to the drivers and leaves room for strategic planning. The factors that overshadow the growth of the market are essential as they can be understood to design different phrases to take advantage of the lucrative opportunities that the growing Precision Medicine Software market offers. In addition, information on the opinions of market experts was used to better understand the market.

Global Precision Medicine Software Market: Segment Analysis

The research report contains certain segments such as application and product type. Each type provides revenue information for the 2015-2026 forecast period. The application segment also provides volume revenue and revenue for the 2015-2026 forecast period. Understanding the segments identifies the importance of the various factors that support Precision Medicine Software market growth.

Global Precision Medicine Software Market: Regional Analysis

The research report includes a detailed study of the regions of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The Precision Medicine Software report was compiled after various factors determining regional growth, such as the economic, environmental, social, technological and political status of the region concerned, were observed and examined. Analysts examined sales, sales, and manufacturer data for each region. This section analyzes sales and volume by region for the forecast period from 2015 to 2026. These analyzes help the reader understand the potential value of investments in a particular region.

Global Precision Medicine Software Market: Competitive Landscape

This section of the report lists various major manufacturers in the market. It helps the reader understand the strategies and collaborations that players focus on to fight competition in the market. The full report provides a significant microscopic overview of the Precision Medicine Software market. Readers can identify manufacturers footprints by knowing manufacturers global earnings, manufacturers world market prices, and manufacturers sales for the 2015-2019 forecast period.

Ask For Discounts, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=27982&utm_source=COD&utm_medium=007

Table of Content

1 Introduction of Precision Medicine Software Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Precision Medicine Software Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Precision Medicine Software Market, By Deployment Model

5.1 Overview

6 Precision Medicine Software Market, By Solution

6.1 Overview

7 Precision Medicine Software Market, By Vertical

7.1 Overview

8 Precision Medicine Software Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Precision Medicine Software Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @https://www.verifiedmarketresearch.com/product/Precision-Medicine-Software-Market/?utm_source=COD&utm_medium=007

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080 UK: +44 (203)-411-9686 APAC: +91 (902)-863-5784 US Toll Free: +1 (800)-7821768

Email: [emailprotected]

View original post here:
Precision Medicine Software Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 - Cole of Duty

Read the Rest...

New Study Reveals Cloth Masks can Obstruct up to 99% of Particles; Experts say it can Stop the Spread of COVID – Science Times

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on New Study Reveals Cloth Masks can Obstruct up to 99% of Particles; Experts say it can Stop the Spread of COVID – Science Times

In a new study, scientists claim that cloth masks can forestall the spread of COVID-19 by clocking up to 99% of harmful particles. Daily Mail reports that Canadian researchers describe how cloth masks, particularly with several layers, can hinder viruses carried by microscopic particles in the air.

When a person coughs or sneezes, cloth layers of a face mask can reduce the amount of infectious particles traveling through the air, the researchers explain. Furthermore, the layers of cloth could also prevent the virus-carrying particles from settling on surfaces.

According to the authors of the study, various combinations of cloth such as cotton-flannel were found to block more than 90 percent of particles. Moreover, a three-layered mask can reduce pathogens' airborne transmission and surface contamination by up to 99 percent.

Although the researchers don't guarantee that cotton masks will indeed provide full protection from SARS-CoV-2, they claim that the results of their study clarify the efficiency of cotton masks when it comes to closing off potentially harmful particles.

Furthermore, they say that their review suggests that cloth can block particles, even aerosol-sized particles, supporting Canadian public health policy on the issue. The findings of their study were published in the medical journal Annals of Internal Medicine.

Also Read: Scientists Show How To Make A DIY Mask That is 80-90% As Effective As Surgical Mask

The Centers for Disease Control and Prevention and the US Public Health Institute both advocate the use of cloth masks in an open space.

The researchers have discovered that cloth can block more than five micrometers in diameter. This means a virus-loaded particle discharged by an infected mask wearer is kept within the mask, furthermore keeping the virus from staying suspended in the air or resting onto a surface.

The team examined evidence on masks obtained from almost a hundred years of research and found strong evidence demonstrating the reduction of contamination in the air and surfaces using cloth and cloth-based covers.

According to the authors, masks are not checked separately for every pathogen. Moreover, filtration efficiency relies on particles of different sizes, regardless of which pathogen the particle holds.

A study from 2010 suggests that because the filtration rate of cloth differs, cotton from everyday clothing items, like layers of a scarf, t-shirt, and sweatshirt, may only have a filtration efficiency between ten to 40 percent.

However, experts say that there can be one risky disadvantage from wearing multiple layers of cloth over one's face; it makes it harder to breathe.

According to the first author of the study, Catherine Clase, more layers will allow the wearer to have more protection both inward and outward but will make it more difficult for them to breathe. She recommends that people with conditions that make it hard for them to breathe, and children under two are not recommended to wear masks.

Although previous studies reveal that cloth masks can block infectious particles, the researchers stress that homemade masks are not equivalent to a substitute for medically certified personal protective equipment.

In their paper, the team also mentions recognizing the potential for unintentional consequences, like the usage of formal personal protective equipment by the general public, improper use of cloth masks, or reduced hand hygiene due to a false sense of security. They claim that these can be avoided by controlling the distribution of personal protective equipment, public education, giving clear messages, and social pressure.

Furthermore, they say that advocating that the public make and use cloth masks also changes the cost of a public health intervention from society to the individual. They add that such practice is objectionable for people living in poverty and low-resource areas.

Read Also: Are Face Masks Effective Against COVID-19? The Pros and the Cons

See more here:
New Study Reveals Cloth Masks can Obstruct up to 99% of Particles; Experts say it can Stop the Spread of COVID - Science Times

Read the Rest...

Addressing the potential impact of coronavirus disease (COVID-19) on Chinese Medicine Injection Market: Analysis and In-depth Study on Chinese…

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Addressing the potential impact of coronavirus disease (COVID-19) on Chinese Medicine Injection Market: Analysis and In-depth Study on Chinese…

Companies in the Chinese Medicine Injection market are vying suggestive steps to tackle the challenges resulting from the COVID-19 (Coronavirus) pandemic. Exhaustive research about COVID-19 is providing present-day techniques and alternative methods to mitigate the impact on Coronavirus on the revenue of the Chinese Medicine Injection market.

The report on the Chinese Medicine Injection market provides a birds eye view of the current proceedings and advancements within the Chinese Medicine Injection landscape. Further, the report ponders over the various factors that are likely to impact the overall dynamics of the Chinese Medicine Injection market over the forecast period (20XX-20XX) including the current trends, business expansion opportunities and restraining factors amongst others.

As per the market report suggested by ResearchMoz.us, the global Chinese Medicine Injection market is expected to register a CAGR growth of ~XX% during the forecast period and attain a value of ~US$XX by the end of 20XX. Further, the report suggests that the growth of the Chinese Medicine Injection market is largely influenced by a range of factors including, emphasis on R&D innovations by market players, surging investments to increase product portfolio, and favorable regulatory policies among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2655796&source=atm

Questions Related to the Chinese Medicine Injection Market Explained:

Competitive Landscape

The report provides critical insights related to the leading players operating in the Chinese Medicine Injection market. The revenue generated, market presence, product range, and financials of each company are enclosed in the report.

Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the markets growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026. A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market experts opinions have been taken to understand the market better. Global Chinese Medicine Injection Market: Segment Analysis The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Global Chinese Medicine Injection Market: Regional Analysis The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Chinese Medicine Injection Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. Following are the segments covered by the report are: Detoxification Cardiovascular Disease Medication Cerebrovascular Disease Medication Anti-tumor Drugs other By Application: Adult Children Key Players: The Key manufacturers that are operating in the global Chinese Medicine Injection market are: Green Valley Pharma Changbaishan Pharmaceutical Zhejiang Kanglaite Pharmaceutical Qingfeng Pharmaceutical Group Buchang Pharmaceutical Livzon ZBD Pharmaceutical Chase Sun Pharmaceutical Wuzhou Pharmaceutical Yusheng Pharmaceutical Harbin Pharmaceutical Group Fusen Pharmaceutical Gerun Pharmaceutical Shineway Pharmaceutical Competitive Landscape The analysts have provided a comprehensive analysis of the competitive landscape of the global Chinese Medicine Injection market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2655796&source=atm

Regional Landscape

The regional landscape of the report provides resourceful insights related to the revenue share analysis of the Chinese Medicine Injection market in different regions. Further, the market attractiveness of each region provides players a clear understanding of the overall growth potential in each regional market.

End-User Analysis

The report provides an in-depth understanding of the various end-users of the Chinese Medicine Injection along with the market share, size, and revenue generated by each end-user.

Important Information that can be extracted from the Report:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2655796&licType=S&source=atm

Read the original:
Addressing the potential impact of coronavirus disease (COVID-19) on Chinese Medicine Injection Market: Analysis and In-depth Study on Chinese...

Read the Rest...

Sports Medicine Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 – Cole of Duty

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Sports Medicine Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 – Cole of Duty

New Jersey, United States, The Sports Medicine Market report examines the market situation and prospects and represents the size of the Sports Medicine market (value and volume) and the share by company, type, application and region. The general trends and opportunities of Sports Medicine are also taken into account when examining the Sports Medicine industry. Sports Medicine The market report focuses on the following section: Analysis of the Sports Medicine industry by transfer into different segments; the main types of products that fall within the scope of the report.

This Sports Medicine market report is a complete analysis of the Sports Medicine market based on an in-depth primary and secondary analysis. The scope of the Sports Medicine market report includes global and regional sales, product consumption in terms of volume and value. The Sports Medicine market report contains an estimate of revenue, CAGR and total revenue. The knowledge gathered in world trade Sports Medicine is presented in figures, tables, pie charts and graphics.

Get | Research Sample Copy By Using Corporate Mail ID @https://www.verifiedmarketresearch.com/download-sample/?rid=3753&utm_source=COD&utm_medium=007

Top 10 Companies in the Global Sports Medicine Market Research Report:

Global Sports Medicine Market: Drivers and Restrains

The research report included analysis of various factors that increase market growth. These are trends, restrictions and drivers that change the market positively or negatively. This section also contains information on various segments and applications that may affect the market in the future. Detailed information is based on current trends and historical milestones. This section also includes an analysis of sales volume on the Sports Medicine market and for each type from 2015 to 2026. This section mentions sales volume by region from 2015 to 2026. The price analysis is included in the report Type of year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020 and total price from 2015 to 2026.

An in-depth assessment of the restrictions contained in the report describes the contrast to the drivers and leaves room for strategic planning. The factors that overshadow the growth of the market are essential as they can be understood to design different phrases to take advantage of the lucrative opportunities that the growing Sports Medicine market offers. In addition, information on the opinions of market experts was used to better understand the market.

Global Sports Medicine Market: Segment Analysis

The research report contains certain segments such as application and product type. Each type provides revenue information for the 2015-2026 forecast period. The application segment also provides volume revenue and revenue for the 2015-2026 forecast period. Understanding the segments identifies the importance of the various factors that support Sports Medicine market growth.

Global Sports Medicine Market: Regional Analysis

The research report includes a detailed study of the regions of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The Sports Medicine report was compiled after various factors determining regional growth, such as the economic, environmental, social, technological and political status of the region concerned, were observed and examined. Analysts examined sales, sales, and manufacturer data for each region. This section analyzes sales and volume by region for the forecast period from 2015 to 2026. These analyzes help the reader understand the potential value of investments in a particular region.

Global Sports Medicine Market: Competitive Landscape

This section of the report lists various major manufacturers in the market. It helps the reader understand the strategies and collaborations that players focus on to fight competition in the market. The full report provides a significant microscopic overview of the Sports Medicine market. Readers can identify manufacturers footprints by knowing manufacturers global earnings, manufacturers world market prices, and manufacturers sales for the 2015-2019 forecast period.

Ask For Discounts, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=3753&utm_source=COD&utm_medium=007

Table of Content

1 Introduction of Sports Medicine Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Sports Medicine Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Sports Medicine Market, By Deployment Model

5.1 Overview

6 Sports Medicine Market, By Solution

6.1 Overview

7 Sports Medicine Market, By Vertical

7.1 Overview

8 Sports Medicine Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Sports Medicine Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @https://www.verifiedmarketresearch.com/product/global-sports-medicine-market-size-and-forecast-to-2025/?utm_source=COD&utm_medium=007

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080 UK: +44 (203)-411-9686 APAC: +91 (902)-863-5784 US Toll Free: +1 (800)-7821768

Email: [emailprotected]

View post:
Sports Medicine Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 - Cole of Duty

Read the Rest...

COVID-19: Potential impact on Chinese Medicine Polysaccharide Market: Segmentation, Industry trends and Development to 2026 – Cole of Duty

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on COVID-19: Potential impact on Chinese Medicine Polysaccharide Market: Segmentation, Industry trends and Development to 2026 – Cole of Duty

Analysis of the Global Chinese Medicine Polysaccharide Market

A recently published market report on the Chinese Medicine Polysaccharide market highlights the pitfalls that companies might come across due to the unprecedented outbreak of COVID-19 (Coronavirus). Buyers can request comprehensive market analysis of Coronavirus and its impact on the Chinese Medicine Polysaccharide market to mitigate revenue losses.

This market research report on the Chinese Medicine Polysaccharide market published by Chinese Medicine Polysaccharide derives current insights about the competitive landscape of the Chinese Medicine Polysaccharide market. Further, the report unfolds detailed analysis of different segments of the Chinese Medicine Polysaccharide market and offers a thorough understanding of the growth potential of each market segment over the assessment period (20XX-20XX).

According to the analysts at Chinese Medicine Polysaccharide , the Chinese Medicine Polysaccharide market is predicted to register a CAGR growth of ~XX% during the assessment and reach a value of ~US$ XX by the end of 20XX. The report analyzes the micro and macro-economic factors that are projected to influence the growth of the Chinese Medicine Polysaccharide market in the coming decade.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2634627&source=atm

Key Insights Highlighted in the Report

Segmentation of the Chinese Medicine Polysaccharide Market

The presented report elaborate on the Chinese Medicine Polysaccharide market into different segments and ponders over the current and future business potentials of each segment. The report showcases the year-on-year growth of each segment and ponders upon the different factors that are likely to influence the growth of each market segment.

The various segments of the Chinese Medicine Polysaccharide market explained in the report include:

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Chinese Medicine Polysaccharide market is segmented into Reagent grade Pharmaceutical Grade Food grade

Segment by Application Food & Suppliments Medicine Other

Global Chinese Medicine Polysaccharide Market: Regional Analysis The Chinese Medicine Polysaccharide market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Chinese Medicine Polysaccharide market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Chinese Medicine Polysaccharide Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Chinese Medicine Polysaccharide market include: Alpha Group Holdings Ltd INFINITUSCHINACOMPANY LTD Xian B-Thriving I/E Co.,Ltd Hindawi

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2634627&source=atm

Important doubts related to the Chinese Medicine Polysaccharide market clarified in the report:

Why Choose Chinese Medicine Polysaccharide

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2634627&licType=S&source=atm

Originally posted here:
COVID-19: Potential impact on Chinese Medicine Polysaccharide Market: Segmentation, Industry trends and Development to 2026 - Cole of Duty

Read the Rest...

Radiopharmaceuticals in Nuclear Medicine Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 -…

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Radiopharmaceuticals in Nuclear Medicine Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 -…

New Jersey, United States, The Radiopharmaceuticals in Nuclear Medicine Market report examines the market situation and prospects and represents the size of the Radiopharmaceuticals in Nuclear Medicine market (value and volume) and the share by company, type, application and region. The general trends and opportunities of Radiopharmaceuticals in Nuclear Medicine are also taken into account when examining the Radiopharmaceuticals in Nuclear Medicine industry. Radiopharmaceuticals in Nuclear Medicine The market report focuses on the following section: Analysis of the Radiopharmaceuticals in Nuclear Medicine industry by transfer into different segments; the main types of products that fall within the scope of the report.

This Radiopharmaceuticals in Nuclear Medicine market report is a complete analysis of the Radiopharmaceuticals in Nuclear Medicine market based on an in-depth primary and secondary analysis. The scope of the Radiopharmaceuticals in Nuclear Medicine market report includes global and regional sales, product consumption in terms of volume and value. The Radiopharmaceuticals in Nuclear Medicine market report contains an estimate of revenue, CAGR and total revenue. The knowledge gathered in world trade Radiopharmaceuticals in Nuclear Medicine is presented in figures, tables, pie charts and graphics.

Get | Research Sample Copy By Using Corporate Mail ID @https://www.verifiedmarketresearch.com/download-sample/?rid=27934&utm_source=COD&utm_medium=007

Top 10 Companies in the Global Radiopharmaceuticals in Nuclear Medicine Market Research Report:

Global Radiopharmaceuticals in Nuclear Medicine Market: Drivers and Restrains

The research report included analysis of various factors that increase market growth. These are trends, restrictions and drivers that change the market positively or negatively. This section also contains information on various segments and applications that may affect the market in the future. Detailed information is based on current trends and historical milestones. This section also includes an analysis of sales volume on the Radiopharmaceuticals in Nuclear Medicine market and for each type from 2015 to 2026. This section mentions sales volume by region from 2015 to 2026. The price analysis is included in the report Type of year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020 and total price from 2015 to 2026.

An in-depth assessment of the restrictions contained in the report describes the contrast to the drivers and leaves room for strategic planning. The factors that overshadow the growth of the market are essential as they can be understood to design different phrases to take advantage of the lucrative opportunities that the growing Radiopharmaceuticals in Nuclear Medicine market offers. In addition, information on the opinions of market experts was used to better understand the market.

Global Radiopharmaceuticals in Nuclear Medicine Market: Segment Analysis

The research report contains certain segments such as application and product type. Each type provides revenue information for the 2015-2026 forecast period. The application segment also provides volume revenue and revenue for the 2015-2026 forecast period. Understanding the segments identifies the importance of the various factors that support Radiopharmaceuticals in Nuclear Medicine market growth.

Global Radiopharmaceuticals in Nuclear Medicine Market: Regional Analysis

The research report includes a detailed study of the regions of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The Radiopharmaceuticals in Nuclear Medicine report was compiled after various factors determining regional growth, such as the economic, environmental, social, technological and political status of the region concerned, were observed and examined. Analysts examined sales, sales, and manufacturer data for each region. This section analyzes sales and volume by region for the forecast period from 2015 to 2026. These analyzes help the reader understand the potential value of investments in a particular region.

Global Radiopharmaceuticals in Nuclear Medicine Market: Competitive Landscape

This section of the report lists various major manufacturers in the market. It helps the reader understand the strategies and collaborations that players focus on to fight competition in the market. The full report provides a significant microscopic overview of the Radiopharmaceuticals in Nuclear Medicine market. Readers can identify manufacturers footprints by knowing manufacturers global earnings, manufacturers world market prices, and manufacturers sales for the 2015-2019 forecast period.

Ask For Discounts, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=27934&utm_source=COD&utm_medium=007

Table of Content

1 Introduction of Radiopharmaceuticals in Nuclear Medicine Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Radiopharmaceuticals in Nuclear Medicine Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Radiopharmaceuticals in Nuclear Medicine Market, By Deployment Model

5.1 Overview

6 Radiopharmaceuticals in Nuclear Medicine Market, By Solution

6.1 Overview

7 Radiopharmaceuticals in Nuclear Medicine Market, By Vertical

7.1 Overview

8 Radiopharmaceuticals in Nuclear Medicine Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Radiopharmaceuticals in Nuclear Medicine Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @https://www.verifiedmarketresearch.com/product/Radiopharmaceuticals-in-Nuclear-Medicine-Market/?utm_source=COD&utm_medium=007

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080 UK: +44 (203)-411-9686 APAC: +91 (902)-863-5784 US Toll Free: +1 (800)-7821768

Email: [emailprotected]

Originally posted here:
Radiopharmaceuticals in Nuclear Medicine Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 -...

Read the Rest...

Assessing the Fallout From the Coronavirus Pandemic 2-butene-1,4-diol (B2D) Market: Quantitative Analysis, Current and Future Trends, 2019-2027 – 3rd…

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Assessing the Fallout From the Coronavirus Pandemic 2-butene-1,4-diol (B2D) Market: Quantitative Analysis, Current and Future Trends, 2019-2027 – 3rd…

In 2029, the 2-butene-1,4-diol (B2D) market is spectated to surpass ~US$ xx Mn/Bn with a CAGR of xx% over the forecast period. The 2-butene-1,4-diol (B2D) market clicked a value of ~US$ xx Mn/Bn in 2018. Region is expected to account for a significant market share, where the 2-butene-1,4-diol (B2D) market size is projected to inflate with a CAGR of xx% during the forecast period.

In the 2-butene-1,4-diol (B2D) market research study, 2018 is considered as the base year, and 2019-2029 is considered as the forecast period to predict the market size. Important regions emphasized in the report include region 1 (country 1, country2), region 2 (country 1, country2), and region 3 (country 1, country2).

The report on the 2-butene-1,4-diol (B2D) market provides a birds eye view of the current proceeding within the 2-butene-1,4-diol (B2D) market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the 2-butene-1,4-diol (B2D) market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2682237&source=atm

Global 2-butene-1,4-diol (B2D) market report on the basis of market players

The report examines each 2-butene-1,4-diol (B2D) market player according to its market share, production footprint, and growth rate. SWOT analysis of the players (strengths, weaknesses, opportunities and threats) has been covered in this report. Further, the 2-butene-1,4-diol (B2D) market study depicts the recent launches, agreements, R&D projects, and business strategies of the market players including

Segment by Type, the 2-butene-1,4-diol (B2D) market is segmented into Refined Product Crude Product

Segment by Application Medicine Pesticide Paper Plating Additive Plastic Other

Global 2-butene-1,4-diol (B2D) Market: Regional Analysis The 2-butene-1,4-diol (B2D) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the 2-butene-1,4-diol (B2D) market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

Global 2-butene-1,4-diol (B2D) Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global 2-butene-1,4-diol (B2D) market include: Ashland Changzhou Jiayan Chemical Co.,Ltd. Dezhou Tianyu Chemical Industry

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2682237&source=atm

The 2-butene-1,4-diol (B2D) market report answers the following queries:

The 2-butene-1,4-diol (B2D) market report provides the below-mentioned information:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2682237&licType=S&source=atm

Research Methodology of 2-butene-1,4-diol (B2D) Market Report

The global 2-butene-1,4-diol (B2D) market study covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). Both top-down and bottom-up approaches have been used to calculate and authenticate the market size of the 2-butene-1,4-diol (B2D) market, and predict the scenario of various sub-markets in the overall market. Primary and secondary research has been thoroughly performed to analyze the prominent players and their market share in the 2-butene-1,4-diol (B2D) market. Further, all the numbers, segmentation, and shares have been gathered using authentic primary and secondary sources.

See the article here:
Assessing the Fallout From the Coronavirus Pandemic 2-butene-1,4-diol (B2D) Market: Quantitative Analysis, Current and Future Trends, 2019-2027 - 3rd...

Read the Rest...

The Economic Impact of Coronavirus on Frankincense Oil Market Analysis 2019 Growth by Top Companies and Trends by Types, Treatment, Diagnosis and…

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on The Economic Impact of Coronavirus on Frankincense Oil Market Analysis 2019 Growth by Top Companies and Trends by Types, Treatment, Diagnosis and…

Global Frankincense Oil Market Growth Projection

The new report on the global Frankincense Oil market is an extensive study on the overall prospects of the Frankincense Oil market over the assessment period. Further, the report provides a thorough understanding of the key dynamics of the Frankincense Oil market including the current trends, opportunities, drivers, and restraints. The report introspects the micro and macro-economic factors that are expected to nurture the growth of the Frankincense Oil market in the upcoming years and the impact of the COVID-19 pandemic on the Frankincense Oil . In addition, the report offers valuable insights pertaining to the supply chain challenges market players are likely to face in the upcoming months and solutions to tackle the same.

The report suggests that the global Frankincense Oil market is projected to reach a value of ~US$XX by the end of 2029 and grow at a CAGR of ~XX% through the forecast period (2019-2029). The key indicators such as the year-on-year (Y-o-Y) growth and CAGR growth of the Frankincense Oil market are discussed in detail in the presented report. This data is likely to provide readers an understanding of qualitative and quantitative growth prospects of the Frankincense Oil market over the considered assessment period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2634504&source=atm

The report clarifies the following doubts related to the Frankincense Oil market:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2634504&source=atm

Segmentation of the Frankincense Oil Market

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Frankincense Oil market is segmented into Natural Synthetic

Segment by Application Medicine Skin care Oral Care Others

Global Frankincense Oil Market: Regional Analysis The Frankincense Oil market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Frankincense Oil market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Frankincense Oil Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Frankincense Oil market include: AMEO De Monchy Aromatics DoTERRA AOS Products Private Limited Natures Sunshine Products TriVita

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2634504&licType=S&source=atm

Vital Information Enclosed in the Report

Read more:
The Economic Impact of Coronavirus on Frankincense Oil Market Analysis 2019 Growth by Top Companies and Trends by Types, Treatment, Diagnosis and...

Read the Rest...

Assessing the Fallout From the Coronavirus Pandemic Rape Honey Volume Analysis, Segments, Value Share and Key Trends 2019-2020 – 3rd Watch News

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Assessing the Fallout From the Coronavirus Pandemic Rape Honey Volume Analysis, Segments, Value Share and Key Trends 2019-2020 – 3rd Watch News

The report on the Rape Honey market provides a birds eye view of the current proceeding within the Rape Honey market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Rape Honey market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Rape Honey market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

The recent published research report sheds light on critical aspects of the global Rape Honey market such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report helps the readers to draw a suitable conclusion and clearly understand the current and future scenario and trends of global Rape Honey market. The research study comes out as a compilation of useful guidelines for players to understand and define their strategies more efficiently in order to keep themselves ahead of their competitors. The report profiles leading companies of the global Rape Honey market along with the emerging new ventures who are creating an impact on the global market with their latest innovations and technologies.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2631795&source=atm

The recent published study includes information on key segmentation of the global Rape Honey market on the basis of type/product, application and geography (country/region). Each of the segments included in the report is studies in relations to different factors such as market size, market share, value, growth rate and other quantitate information.

The competitive analysis included in the global Rape Honey market study allows their readers to understand the difference between players and how they are operating amounts themselves on global scale. The research study gives a deep insight on the current and future trends of the market along with the opportunities for the new players who are in process of entering global Rape Honey market. Market dynamic analysis such as market drivers, market restraints are explained thoroughly in the most detailed and easiest possible manner. The companies can also find several recommendations improve their business on the global scale.

The readers of the Rape Honey Market report can also extract several key insights such as market size of varies products and application along with their market share and growth rate. The report also includes information for next five years as forested data and past five years as historical data and the market share of the several key information.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2631795&source=atm

Global Rape Honey Market by Companies:

The company profile section of the report offers great insights such as market revenue and market share of global Rape Honey market. Key companies listed in the report are:

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Rape Honey market is segmented into Extracted Honey Pressed Honey Comb Honey

Segment by Application Cakes and Pastries Segments Skin Care Products Medicine Sugar Coatings

Global Rape Honey Market: Regional Analysis The Rape Honey market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Rape Honey market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Rape Honey Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Rape Honey market include: Billy Bee Products Comvita HoneyLab Dabur Dutch Gold Honey Barkman Honey R Stephens Apiary Savannah Bee Sioux Honey Bee Maid Honey Beeyond the Hive Rowse Honey Capilano Honey Golden Acres Honey Little Bee Polar-Honey Steens The Honey Yanbian Baolixiang Dalian Sangdi Honeybee Shanghai Guanshengyuan

Global Rape Honey Market by Geography:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2631795&licType=S&source=atm

Some of the Major Highlights of TOC covers in Rape Honey Market Report:

Chapter 1: Methodology & Scope of Rape Honey Market

Chapter 2: Executive Summary of Rape Honey Market

Chapter 3: Rape Honey Industry Insights

Chapter 4: Rape Honey Market, By Region

Chapter 5: Company Profile

And Continue

Read the original post:
Assessing the Fallout From the Coronavirus Pandemic Rape Honey Volume Analysis, Segments, Value Share and Key Trends 2019-2020 - 3rd Watch News

Read the Rest...

Global Nanotechnology in Drug Delivery Markets, 2020-2027 with Profiles of 43 Industry Players – Yahoo Finance

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Global Nanotechnology in Drug Delivery Markets, 2020-2027 with Profiles of 43 Industry Players – Yahoo Finance

DUBLIN, May 28, 2020 /PRNewswire/ -- The "Nanotechnology in Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global analysis and forecast periods covered are 2020-2027 (current & future analysis) and 2012-2019 (historic review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

Amid the COVID-19 crisis and the looming economic recession, the Nanotechnology in Drug Delivery market worldwide will grow by a projected US $124.7 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 22.6%.

Nanocrystals, one of the segments analyzed and sized in this study, is forecast to grow at over 20.2% and reach a market size of US $83.1 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Nanocrystals market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 17% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US $4.1 Billion to the region's size over the next 7 to 8 years. In addition, over US $3.7 Billion worth of projected demand in the region will come from Rest of European markets. In Japan, the Nanocrystals segment will reach a market size of US $3 Billion by the close of the analysis period.

Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Nanotechnology in Drug Delivery market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 25.2% over the next couple of years and add approximately US $20.2 Billion in terms of addressable market opportunity.

Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Nanotechnology in Drug Delivery market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Key Topics Covered

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/gz8elw

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-nanotechnology-in-drug-delivery-markets-2020-2027-with-profiles-of-43-industry-players-301067245.html

SOURCE Research and Markets

More:
Global Nanotechnology in Drug Delivery Markets, 2020-2027 with Profiles of 43 Industry Players - Yahoo Finance

Read the Rest...

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and… – Azizsalon News

§ May 29th, 2020 § Filed under Nano Medicine Comments Off on Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and… – Azizsalon News

Nanomedicine Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

Nanomedicine Market Drivers and Restrains: Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/39223

The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis: Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis: Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscape Major Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/39223

Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics Treatments Nanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological Diseases Nanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives Oncology Nanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East Africa Nanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.

MAJOR TOC OF THE REPORT

Chapter One: Nanomedicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanomedicine Market Competition, by Players

Chapter Four: Global Nanomedicine Market Size by Regions

Chapter Five: North America Nanomedicine Revenue by Countries

Chapter Six: Europe Nanomedicine Revenue by Countries

Chapter Seven: Asia-Pacific Nanomedicine Revenue by Countries

Chapter Eight: South America Nanomedicine Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanomedicine by Countries

Chapter Ten: Global Nanomedicine Market Segment by Type

Chapter Eleven: Global Nanomedicine Market Segment by Application

Chapter Twelve: Global Nanomedicine Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanomedicine Market Report at: https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Read the original here:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and... - Azizsalon News

Read the Rest...

« Older Entries Newer Entries »



Page 21234..1020..»